G-CSF rescues tumor growth and neo-angiogenesis during liver metastasis under host angiopoietin-2 deficiency
Suppression of neo-angiogenesis is a clinically used anti-tumor strategy with new targets such as angiopoietin-2 (Ang2) being proposed. However, the functions of Ang2 in vascular remodeling, inflammation and tumor growth are not consistent. We examined effect of depletion of host Ang2 on liver colon...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2013
|
| _version_ | 1826269378248704000 |
|---|---|
| author | Im, J Tapmeier, T Balathasan, L Gal, A Yameen, S Hill, S Smart, S Noterdaeme, O Kelly, M Brady, M Fu, W Kruse, K Bernhard, E Augustin, H Muschel, R |
| author_facet | Im, J Tapmeier, T Balathasan, L Gal, A Yameen, S Hill, S Smart, S Noterdaeme, O Kelly, M Brady, M Fu, W Kruse, K Bernhard, E Augustin, H Muschel, R |
| author_sort | Im, J |
| collection | OXFORD |
| description | Suppression of neo-angiogenesis is a clinically used anti-tumor strategy with new targets such as angiopoietin-2 (Ang2) being proposed. However, the functions of Ang2 in vascular remodeling, inflammation and tumor growth are not consistent. We examined effect of depletion of host Ang2 on liver colony formation using Ang2 deficient (Ang2-/-) mice. Surprisingly, the metastatic colonies formed in Ang2-/- mice were larger than those in the wild type. These colonies had greater vascular density with more pericyte coverage than the vessels in liver colonies in the wild type. Liver VEGF concentration in both genotypes was equivalent, and thus, the differences appeared VEGF independent. However, after colony formation, the serum concentration of granulocyte-colony stimulating factor (G-CSF) and CXCL1 in Ang2-/- mice was 12 and 6 times greater than after colony formation in wild type. Increase of these two cytokines was associated with two times greater numbers of neutrophils recruited to the liver. Two times more Tie2+/CD11b+/CD31- cells were present in the tumors in Ang2-/- than in the wild type livers. These results suggest that the depletion of host Ang2 induced compensatory VEGF-independent angiogenic mechanisms and thus enhanced liver metastatic colony growth and colony vascularity. They further indicate organotypic differences in response to tumor metastasis. In contrast, Ang2 deficiency inhibited tumor growth during metastatic colony formation in the lung, consistent with the reports of decreased pulmonary seeding of tumor cells after pharmacological inhibition of Ang2. Further studies are thus required to assess the effects of pharmacological Ang2 blockade for cancer patients particularly in the liver. What's new? Suppression of neo-angiogenesis is a clinically used anti-tumor strategy, with new targets such as angiopoietin-2 (Ang2) being proposed. However, the functions of Ang2 in vascular remodeling, inflammation, and tumor growth are not consistent. This work shows that genetic depletion of host Ang2 unexpectedly enhanced liver metastatic colony vascularity and growth. The more aggressive neo-angiogenesis and tumor growth were associated with VEGF-independent angiogenic mechanisms, including G-CSF production and neutrophil infiltration. Further studies are thus required to assess the effects of pharmacological Ang2 blockade for cancer patients, particularly in the liver. Copyright © 2012 UICC. |
| first_indexed | 2024-03-06T21:24:07Z |
| format | Journal article |
| id | oxford-uuid:427f5c17-6ece-4141-a54b-d21f3a245123 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T21:24:07Z |
| publishDate | 2013 |
| record_format | dspace |
| spelling | oxford-uuid:427f5c17-6ece-4141-a54b-d21f3a2451232022-03-26T14:49:52ZG-CSF rescues tumor growth and neo-angiogenesis during liver metastasis under host angiopoietin-2 deficiencyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:427f5c17-6ece-4141-a54b-d21f3a245123EnglishSymplectic Elements at Oxford2013Im, JTapmeier, TBalathasan, LGal, AYameen, SHill, SSmart, SNoterdaeme, OKelly, MBrady, MFu, WKruse, KBernhard, EAugustin, HMuschel, RSuppression of neo-angiogenesis is a clinically used anti-tumor strategy with new targets such as angiopoietin-2 (Ang2) being proposed. However, the functions of Ang2 in vascular remodeling, inflammation and tumor growth are not consistent. We examined effect of depletion of host Ang2 on liver colony formation using Ang2 deficient (Ang2-/-) mice. Surprisingly, the metastatic colonies formed in Ang2-/- mice were larger than those in the wild type. These colonies had greater vascular density with more pericyte coverage than the vessels in liver colonies in the wild type. Liver VEGF concentration in both genotypes was equivalent, and thus, the differences appeared VEGF independent. However, after colony formation, the serum concentration of granulocyte-colony stimulating factor (G-CSF) and CXCL1 in Ang2-/- mice was 12 and 6 times greater than after colony formation in wild type. Increase of these two cytokines was associated with two times greater numbers of neutrophils recruited to the liver. Two times more Tie2+/CD11b+/CD31- cells were present in the tumors in Ang2-/- than in the wild type livers. These results suggest that the depletion of host Ang2 induced compensatory VEGF-independent angiogenic mechanisms and thus enhanced liver metastatic colony growth and colony vascularity. They further indicate organotypic differences in response to tumor metastasis. In contrast, Ang2 deficiency inhibited tumor growth during metastatic colony formation in the lung, consistent with the reports of decreased pulmonary seeding of tumor cells after pharmacological inhibition of Ang2. Further studies are thus required to assess the effects of pharmacological Ang2 blockade for cancer patients particularly in the liver. What's new? Suppression of neo-angiogenesis is a clinically used anti-tumor strategy, with new targets such as angiopoietin-2 (Ang2) being proposed. However, the functions of Ang2 in vascular remodeling, inflammation, and tumor growth are not consistent. This work shows that genetic depletion of host Ang2 unexpectedly enhanced liver metastatic colony vascularity and growth. The more aggressive neo-angiogenesis and tumor growth were associated with VEGF-independent angiogenic mechanisms, including G-CSF production and neutrophil infiltration. Further studies are thus required to assess the effects of pharmacological Ang2 blockade for cancer patients, particularly in the liver. Copyright © 2012 UICC. |
| spellingShingle | Im, J Tapmeier, T Balathasan, L Gal, A Yameen, S Hill, S Smart, S Noterdaeme, O Kelly, M Brady, M Fu, W Kruse, K Bernhard, E Augustin, H Muschel, R G-CSF rescues tumor growth and neo-angiogenesis during liver metastasis under host angiopoietin-2 deficiency |
| title | G-CSF rescues tumor growth and neo-angiogenesis during liver metastasis under host angiopoietin-2 deficiency |
| title_full | G-CSF rescues tumor growth and neo-angiogenesis during liver metastasis under host angiopoietin-2 deficiency |
| title_fullStr | G-CSF rescues tumor growth and neo-angiogenesis during liver metastasis under host angiopoietin-2 deficiency |
| title_full_unstemmed | G-CSF rescues tumor growth and neo-angiogenesis during liver metastasis under host angiopoietin-2 deficiency |
| title_short | G-CSF rescues tumor growth and neo-angiogenesis during liver metastasis under host angiopoietin-2 deficiency |
| title_sort | g csf rescues tumor growth and neo angiogenesis during liver metastasis under host angiopoietin 2 deficiency |
| work_keys_str_mv | AT imj gcsfrescuestumorgrowthandneoangiogenesisduringlivermetastasisunderhostangiopoietin2deficiency AT tapmeiert gcsfrescuestumorgrowthandneoangiogenesisduringlivermetastasisunderhostangiopoietin2deficiency AT balathasanl gcsfrescuestumorgrowthandneoangiogenesisduringlivermetastasisunderhostangiopoietin2deficiency AT gala gcsfrescuestumorgrowthandneoangiogenesisduringlivermetastasisunderhostangiopoietin2deficiency AT yameens gcsfrescuestumorgrowthandneoangiogenesisduringlivermetastasisunderhostangiopoietin2deficiency AT hills gcsfrescuestumorgrowthandneoangiogenesisduringlivermetastasisunderhostangiopoietin2deficiency AT smarts gcsfrescuestumorgrowthandneoangiogenesisduringlivermetastasisunderhostangiopoietin2deficiency AT noterdaemeo gcsfrescuestumorgrowthandneoangiogenesisduringlivermetastasisunderhostangiopoietin2deficiency AT kellym gcsfrescuestumorgrowthandneoangiogenesisduringlivermetastasisunderhostangiopoietin2deficiency AT bradym gcsfrescuestumorgrowthandneoangiogenesisduringlivermetastasisunderhostangiopoietin2deficiency AT fuw gcsfrescuestumorgrowthandneoangiogenesisduringlivermetastasisunderhostangiopoietin2deficiency AT krusek gcsfrescuestumorgrowthandneoangiogenesisduringlivermetastasisunderhostangiopoietin2deficiency AT bernharde gcsfrescuestumorgrowthandneoangiogenesisduringlivermetastasisunderhostangiopoietin2deficiency AT augustinh gcsfrescuestumorgrowthandneoangiogenesisduringlivermetastasisunderhostangiopoietin2deficiency AT muschelr gcsfrescuestumorgrowthandneoangiogenesisduringlivermetastasisunderhostangiopoietin2deficiency |